Tag: sotrovimab

Commentary: What Reverend Martin Luther King, Jr. Would Say About Biden’s New COVID-19 Policy

Admin

Given the Biden administration’s recent effort to prioritize COVID-19 treatments based on race, it is more important than ever that we remember – and practice – the teachings of Reverend Martin Luther King Jr.

Last week, the Food and Drug Administration released new guidance to medical professionals which listed “race or ethnicity” as high risk factors for doctors to consider when prescribing a new monoclonal antibody known as Sotrovimab. Other high-risk factors included obesity, pregnancy, and other health conditions which would make a person less able to fight the virus. The new guidance means a person’s race could qualify him or her for treatment ahead of others who need the drugs.

Biden administration officials have cited high rates of diabetes and other health issues which are prevalent in non-white and non-Hispanic communities as reasons to include the new criteria. Officials in New York and Minnesota have also prioritized treating non-white patients, but they have more overtly cited historic health care disparities as a justification.

Read More

Feds Trim Florida’s Monoclonal Antibody Allotment After State Fueled National Surge in Demand

The Center Square

Florida Gov. Ron DeSantis has spent two months cross-crossing the state promoting sites and clinics that offer monoclonal antibody treatments, an increasingly popular alternative to vaccines for protection from COVID-19.

In fact, so popular that last week, the U.S. Department of Health & Human Services (DHS), while increasing overall supplies by 50%, from 100,000 to 150,000 doses a week nationwide, but capping the number of doses being delivered to Florida and six other Southern states that had previously consumed more than 70% of the nation’s monoclonal antibody treatments.

Read More